Prescription pharmaceuticals in Canada : off-label use

Record details

Physical Description: remote
image/jpeg
image/jpeg
1 electronic text (28 pages) : illustrations.
Publisher: Ottawa, Ontario : Standing Senate Committee on Social Affairs, Science and Technology, 2014.
Distributor: Ottawa, Ontario : Canadian Electronic Library, 2014.

General Note:	"January 2014". Issued as part of the desLibris documents collection.
Bibliography, etc. Note:	Includes bibliographical references.
Formatted Contents Note:	Order of reference -- Members -- Introduction -- Context: Off-Label Use of Prescription Drugs; Health Canada's Role; Provincial/Territorial Role; Overview of the Canadian Situation; Balancing Innovative Drug Use with Patient Safety -- Off-label drug use: issues of concern: The Extent of Off-Label use in Canada; Vulnerable Sub-Groups of the Population; Drugs Used to Treat Rare Diseases; Safety and Effectiveness Data; Awareness and Promotion of Off-label Uses; Informed consent; Access to Medicines -- Enhancing safety and effectiveness of off-label drug use a renewed call for federal leadership and transparency: Optimize the Use of All Electronic Formats; Collect Data on Off-Label Prescribing; Facilitate Research and Information Sharing; Address Off-label Use in Vulnerable Sub-Groups of the Population; Improve Assessments; Expand the Orphan Drug Framework; Additional Observations -- Conclusion -- Appendix A List of recommendations -- Appendix B Witnesses.
System Details Note:	Mode of access: World Wide Web.
Source of Description Note:	Cover title.